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Abstract: A micronucleus is an additional small nucleus formed due to chromosomes or chromosomal fragments fail 
to be incorporated into the nucleus during cell division. In this study, we assessed the utility of micronucleus count-
ing as a screening tool in cervical precancerous lesions in Thinprep cytological test smears under oil immersion. 
High risk HPV was also detected by hybrid capture-2 in Thinprep cytological test smears. Our results showed that 
micronucleus counting was significantly higher in high-grade squamous intraepithelial lesion (HSIL) and invasive 
carcinoma cases compared to low-grade squamous intraepithelial lesion (LSIL) and non-neoplastic cases. Receiver 
operating characteristic (ROC) curve analysis revealed that micronucleus counting possessed a high degree of sen-
sitivity and specificity for identifying HSIL and invasive carcinoma. Cut-off of 7.5 for MN counting gave a sensitivity of 
89.6% and a specificity of 66.7% (P = 0.024 and AUC = 0.892) for detecting HSIL and invasive carcinoma lesions. 
Multiple linear regression analysis showed that only HSIL and invasive cancer lesions not age, duration of marital 
life and number of pregnancy are significantly associated with MN counting. The positive rate of high risk HPV was 
distinctly higher in LSIL, HSIL and invasive cancer than that in non-neoplstic categories. In conclusions, MN evalua-
tion may be viewed as an effective biomarker for cervical cancer screening. The combination of MN count with HPV 
DNA detection and TCT may serve as an effective means to screen precancerous cervical lesions in most developing 
nations.
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Introduction
Cervical cancer is the most common cancer 
among women in developing countries and the 
second most common cancer among women 
globally. In 2008, it accounted for 9% (529,800) 
of new cancer cases and 8% (275,100) of all 
cancer-related deaths among women. More 
than 85% of cases and deaths occurred in 
developing countries, including China [1, 2]. 
Cervical cancer is the only malignant tumor 
with explicit etiology and has some of the best 
prospects in terms of prevention and cure. 
Thinprep cytology test (TCT) is commonly used 
for the investigation in screening cervical can-
cer. HPV testing and others like p16 immunos-
taining would be further applied to estimate 
cervical intraepithelial neoplasia (CIN) after TCT 
screening, which may not develop into invasive 
cancer. This distinctly improves CIN detection 
rate and conduces to the reduction of incidence 
of cervical carcinoma. However, the cost of 
evaluating and treating CIN is high like HPV test-
ing and p16 immunostaining, so they are sel-
dom used for screening in developing nations. 
This may be the reason why, in developing coun-
tries, cervical cancer goes undetected at higher 
frequencies than in developed countries [3, 4]. 
Hence a simple procedure which can be used in 
conjunction with TCT would be of much use in 
better detection of CIN in developing countries.
A micronucleus (MN) is an additional small 
nucleus in the cytoplasm, formed when chro-
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mosomes or chromosomal fragments fail to be 
incorporated into the nucleus during cell divi-
sion. MN test is a well established and widely 
used technique to evaluate chromosomal 
abnormalities resulting from exposure to carci-
nogenic or mutagenic agents [5-7]. Genetic 
abnormalities in malignant tumors are common 
events; hence MN also could serve as a poten-
tial biomarker for predicting cancer risk. 
Katarkar A et al. reported that MN frequency 
can be used with the same effectiveness and 
greater efficiency in early detection of oral pre-
malignant conditions compared with comet 
assay of peripheral blood leucocytes [8]. MN 
frequency in peripheral blood lymphocytes was 
important for evaluation of prognosis of acute 
leukemia patients, and it may reflect progres-
sion of disease to a certain degree [9].
In this study, MN frequency, HPV DNA and cel-
lular changes in TCT smears were detected in a 
large cohort of women with different kinds of 
cervical abnormalities from Xinjiang, China, 
and the association between them was an- 
alyzed.
Materials and methods
Human cervical exfoliated cell smears
250 cases of TCT smears were collected from 
the Department of Pathology, First Affiliated 
Hospital of Xinjiang Medical University and De- 
partment of Pathology, Hospital of Traditional 
Chinese Medicine Affiliated to Xinjiang Medical 
University. Smears were collected from January 
2014 to December 2014. 162 cases of non-
Figure 1. Micronucleus in non-neoplastic pre-
neoplastic cells (Pap stain × 1000). A. Micro-
nucleus in non-neoplastic cells. B. Micronucle-
us in LSIL cells. C. Micronucleus in HSIL cells.
Table 1. MN count in each category
Group N Mean rank of MN count H value P value






Note: using Kruskal-Wallis test.
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neoplasia were obtained comprising 47 normal 
(mean age 39.09±9.78 years, age range 23~60 
years), 57 chronic cervicitis (mean age 40.23± 
10.02 years, age range 22~72 years), 58 atro-
phy (mean age 54.5±10.10 years, age range 
29~73 years), 40 cases of low grade squamous 
intraepithelial lesion (LSIL) (mean age 41.13± 
9.71 years, age range 21~61 years), 21 cases 
of high grade squamous intraepithelial lesion 
(HSIL) (mean age 40.95±9.55 years, age range 
29~70 years) and 27 cases of cervical carcino-
ma (mean age 52.74±11.57 years, age range 
35~82 years). The smears were stained using 
standard Pap methodology and classified using 
the criteria described by The Bethesda System 
(TBS). Smears of atypical squamous cells of 
undetermined significance (ASC-US) and atypi-
cal squamous cells of undetermined signifi-
cance not except high lesions (ASC-H) were 
sorted into relevant diagnosis according to the 
histological results. All of smears were con-
firmed by pathological histology. The inclusion 
criteria were ① a final pathologic diagnosis of 
CIN and cervical carcinoma; ② no radiotherapy 
or chemotherapy; and ③ no serious compli- 
cations. 
Cytological preparation
TCT kit (Hologic, USA) was bought. A cytobrush 
with exfoliated cells collected from uterine cer-
vix was fixed in TCT preserve cytological solu-
tion for 15 min. After discarding the cytobrush, 
the solution bottle was placed into full-auto-
matic slice machine, blended, filtered, and 
transfered into a glass slide. Then the slide was 
stained with Papanicolau staining solution.
MN counting
The TCT smears were analyzed by light micros-
copy under oil immersion (× 1000) separately 
and independently by two scorers. For each 
case, 1000 epithelial cells with well-defined 
nuclei and cellular borders were counted. Cells 
showing features of degeneration and apopto-
sis were not included. Counting was avoided in 
cell clusters and clumps. A micronucleus was 
determined according to the following criteria: 
size less than one-third of the main nucleus, 
clearly included in the cytoplasm on the same 
optical plane as the nucleus and distinctly sep-
arate from the main nucleus with a similar 
staining intensity (Figure 1A-C). An overall MN 
count was expressed as the number of micro-
nucleated cells per 1000 epithelial cells [10]. 
Cervical TCT smear from breast cancer patient 
using cyclophosphamide was used as a posi-
tive control. 
Hybrid capture-2 (HC-2) assay
Detection of hybrid capture-2 kit (Digene, USA) 
was bought. A brush with exfoliated cells col-
lected from uterine cervix was fixed in preserve 
cytological solution. HC-2 was performed ac- 
cording to the manufacture’s instruction. Sim- 
ply, the process included denaturation, hybrid-
ization, capture, amplifying signal and detec-
tion. 13 types of high risk HPV (16, 18, 31, 33, 
35, 39, 45, 51, 52, 56, 58, 59, 68) can be 
detected at a single time. The criteria of judge-
ment: target DNA (any one in 13 types of high 
risk HPV) ≥ 500 copy is considered positive.
Statistical analysis
Data were analyzed using SPSS 20.0 statistical 
software. MN counts were expressed as mean 
rank. Kruskal-Wallis test was used to compare 
quantitative variables, since the data did not 
show normal distribution. The predictive effica-
Figure 2. ROC curve for Micronucleus counts to pre-
dict HSIL and invasive cervical cancer cases. 










0.892 0.063 0.024 0.768 1.000 
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cy of MN counting was assessed using area 
under curve (AUC) generated by a receiver 
operating characteristic (ROC) analysis. The 
effect of demographic parameters like age, 
duration of marital life, number of pregnancies 
on MN counts was analyzed using multiple lin-
ear regression. Fisher exact test was used to 
compare the expression differences of high 
risk HPV across groups. P < 0.05 was consid-
ered to be statistically significant.
Ethics statement
The study was approved by the Ethical Com- 
mittee of the First Affiliated Hospital of Xinjiang 
Medical University, and the informed consent 
forms were signed.
Results
MN counting differences are statistically sig-
nificant across groups
MN counts for the non-neoplastic, preneoplas-
tic and neoplastic categories were showed in 
Table 1. Kruskal-Wallis test yielded significant 
differences for MN counts among groups (P = 
0.000). The MN count of HSIL and invasive can-
cer was significantly higher compared to LSIL 
cases (89.6%) had MN counts ≥ 7.5. Only 2.5% 
of the smears in LSIL category had MN counts 
≥ 7.5.
Only HSIL + lesions not age, duration of mari-
tal life and number of pregnancy are signifi-
cantly associated with MN counting
We also analyzed the effect of demographic 
parameters such as age, duration of marital 
life, number of pregnancies and positivity for 
HSIL + on MN counts. Multiple linear regres-
sion analysis was performed to determine the 
relative contribution of these variables. The 
result revealed that only HSIL + lesions were 
significantly associated with MN counts (P = 
0.000), while age (β = 0.087, P = 0.349), dura-
tion of marital life (β = -0.088, P = 0.313) and 
number of pregnancies (β = -0.016, P = 0.714) 
were not significantly related with MN counts 
(Table 3).
The expression differences of high risk HPV 
are statistically significant among groups
Detection of high risk HPV for the non-neoplas-
tic, preneoplastic and neoplastic categories 
were shown in Table 4. The positive rate of high 
risk HPV was distinctly higher in LSIL, HSIL and 
Table 3. Effect of positivity for HSIL+, age, duration of marital life 






B Std. Error Beta
(Constant) 0.606 0.721 0.84 0.402
Groups 8.001 0.222 0.921 35.992 0.000
Age 0.025 0.027 0.087 0.938 0.349
Duration of marital life -0.025 0.024 -0.088 -1.011 0.313
Times of pregnancies -0.055 0.151 -0.016 -0.367 0.714
Note: using multiple linear regression.
Table 4. HPV detection in each category
Group n N Real case by HPV detection HPV+ P
Cervical cancer 27 27 27 25 0.000
HSIL 21 21 21 17
LSIL 40 40 34 28
Normal 47 47 27 1
Inflammation 57 57 32 2
Atrophy 58 58 22 0
Note: using Fisher exact test.
and the normal, atrophic and 
inflammatory groups, but mic- 
ronucleus occurrence did not 
differ among the women show-
ing the normal, inflammatory 
or atrophic smears (Table 1).
Cut-off of 7.5 for MN count 
provides more than 85% sen-
sitivity and 66% specificity 
for detecting HSIL or invasive 
cancer lesions
The ability of MN counts to 
diagnose HSIL + lesions (HSIL 
or invasive squamous cell car-
cinoma) was analyzed using 
receiver operating characteris-
tic (ROC) curve analysis. ROC 
curve analysis showed that a 
cut-off of 8 for MN count gave 
a sensitivity of 89.6% and a 
specificity of 66.7% (P = 0.024 
and AUC = 0.892) for detecting 
HSIL + lesions (Figure 2; Table 
2). The majority of HSIL + 
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invasive cancer than that in the normal, atro-
phic and inflammatory groups (Table 4, P = 
0.000).
Discussion
Cervical cancer is the consequent result of a 
long process that has its onset in LSIL and HSIL 
precancerous lesions. Vaccination against HPV 
infection, HPV detection and periodical TCT 
screening are effective measures to prevent 
cervical cancer, which may reduce the inci-
dence of cervical cancer further. The cost of 
vaccination against HPV infection and HPV 
detection is expensive, so they are difficult to 
be popular in most developing countries. 
Several studies have indicated an association 
between micronucleus occurrence and pro-
gression of precancerous lesions of cervical 
cancer. MN frequencies increased with higher 
grade of cervical lesions, and MN monitoring 
may be used as an auxiliary measure for moni-
toring women who are at risk of developing into 
cervical cancer in routine cervical cytopatho-
logical examinations [11-15]. 
The present study shows that MN count was 
significantly greater in HSIL + lesions compared 
to LSIL and control group, the results of ROC 
analysis showed that MN counts gave a high 
degree of sensitivity and specificity for identify-
ing HSIL + lesions. Our results indicate that MN 
evaluation in TCT smears may serve as an easy, 
useful biomarker in cervical precancerous les- 
ions screening. Our results were similar to other 
studies. Some reported that MN frequency was 
significantly higher in the women with HSIL or 
cervical cancer than in the women with normal 
cervix or chronic cervicitis or with LSIL [16-18]. 
MN are small, additional nuclei formed by the 
exclusion of chromosomal fragments (clasto-
genesis) or whole chromosomes that are not 
incorporated into the main nuclei because of 
mitotic malfunction (aneugenesis) [19], and 
may be used as markers of genome instability . 
Chromosomal instability are induced early by 
deregulated expression of HPV oncogenes E6 
and E7 resulting in non-diploid nuclei (aneuploi-
dy). Whereas E6 expression may result in failed 
cytokinesis, E7 expression may uncouple cen-
trosome duplication from cell division [20, 21]. 
Consequently, aneuploidy is characteristic for 
HPV transformed lesions even at cervical pre-
cancerous stages [22]. Currently, besides pri-
mary Pap screening, only HPV testing has been 
assessed as a primary screening marker in 
larger population based studies [23, 24]. A 
number of protein biomarkers have been ana-
lyzed in serum to detect cervical cancer, among 
them the SCC antigen [25], VEGF-C [26] and 
CYFRA 21.1 [27]. The methylation of CDH1 and 
CDH2 genes has been analyzed in serum sam-
ples [28]. None of these markers has shown a 
clinical utility superior to the analysis of directly 
sampled exfoliated cells so far. 
Several factors such as age, duration of marital 
life and number of pregnancies are involved in 
cervical carcinogenesis. We did not observe 
any significant variation of MN count with the 
factors. MN counts increased significantly only 
with HSIL or invasive carcinoma lesions. 
Our study also shows that positive expression 
of high risk HPV is significantly higher in precan-
cerous lesions and cervical cancer compared 
to non-neoplastic groups. High risk HPV infec-
tion is the major factor for cervical carcinoma, 
therefore HPV DNA detection is widely used 
clinically as an important means to screen cer-
vical precancerous lesion in advanced nations. 
However, HPVDNA detection serves only as a 
qualitative diagnosis tool. Cost of HPV DNA 
detection is expensive, which is why there is not 
so many of it in most developing nations. We 
suggest that the combination of MN count with 
HPV DNA detection and TCT may serve as an 
effective means to screen precancerous cervi-
cal lesions in developing nations. 
On summary, MN counting may be viewed as a 
simple and convenient test which can be done 
easily on TCT smears and serves as an effec-
tive biomarker for cervical cancer screening in 
conjunction with HPV DNA detection and TCT 
cytological analysis in most developing coun-
tries. A larger scale study will be needed to fur-
ther verify our conclusion.
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